About Us

Kineta is an emerging and sustainable biotech company that fills a void in the biopharmaceutical industry by efficiently advancing therapies from discovery to clinical proof of concept. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research.

Learn about Kineta...

Pipeline

Our research is focused on developing novel immune modulating therapies in neuroscience/pain, virology, immuno-oncology and autoimmune diseases. Kineta‚Äôs AViiD™ Screening Platform is the discovery engine of our innate immune antiviral, vaccine adjuvant and immuno-oncology programs.

Learn about our pipeline...